基本信息 产品详情 公司简介 推荐产品
网站主页 MRPL1 antibody MRPL1抗体
  • MRPL1抗体
  • MRPL1抗体
  • MRPL1抗体

1/3

MRPL1抗体

Rabbit Polyclonal MRPL1 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-14

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
MRPL1抗体
英文名称:
Rabbit Polyclonal MRPL1 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 4977 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
MRPL1

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/30-1/150 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesL1MT; BM022; MRP-L1
WB Predicted band size37 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human MRPL1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-4: K562, HEPG2, 231 and Jurkat cell lysates, Primary antibody: P09651(MRPL1 Antibody) at dilution 1/350, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 7 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P09651(MRPL1 Antibody) at dilution 1/25. (Original magnification: ×200)    


           

参考文献

以下是3篇关于MRPL1抗体的模拟参考文献示例(实际文献需通过学术数据库检索):

---

1. **文献名称**:*MRPL1 Antibody Characterization in Mitochondrial Ribosome Assembly Studies*

**作者**:Chen L, et al.

**摘要**:本研究验证了兔源多克隆MRPL1抗体的特异性,通过Western blot和免疫荧光技术证实其在哺乳动物细胞线粒体中的定位。研究发现MRPL1缺失导致线粒体核糖体大亚基组装异常,提示其在氧化磷酸化相关疾病中的潜在作用。

---

2. **文献名称**:*MRPL1 as a Novel Biomarker in Colorectal Cancer: An Immunohistochemical Approach*

**作者**:Kim S, et al.

**摘要**:利用商业化MRPL1抗体对结直肠癌组织进行免疫组化分析,发现MRPL1表达水平与肿瘤代谢活跃程度正相关。该抗体可作为评估线粒体功能失调和癌症进展的生物标志物。

---

3. **文献名称**:*Development of a Monoclonal Antibody Targeting MRPL1 for Neurodegenerative Disease Models*

**作者**:Gomez-Ramos P, et al.

**摘要**:报道了一种新型小鼠单克隆MRPL1抗体的开发,用于检测阿尔茨海默病模型中线粒体核糖体蛋白表达变化。实验表明,MRPL1下调与神经元能量代谢障碍显著相关。

---

**建议**:

可通过 **PubMed** 或 **Google Scholar** 搜索真实文献,关键词:

`MRPL1 antibody mitochondrial ribosome`、`MRPL1 western blot validation`、`MRPL1 disease biomarker`。

注意筛选近5年文献以获取最新进展。

       

背景信息

The mitochondrial ribosomal protein L1 (MRPL1) is a component of the large subunit of the mitochondrial ribosome, essential for mitochondrial protein synthesis. Mitochondria possess their own ribosomes (mitoribosomes) that translate mitochondrial DNA-encoded mRNAs, producing subunits of the oxidative phosphorylation (OXPHOS) complexes critical for ATP production. MRPL1. encoded by nuclear DNA, is imported into mitochondria and plays a structural or functional role in maintaining mitoribosome integrity and facilitating translation.

MRPL1-specific antibodies are vital tools for studying mitochondrial gene expression, ribosome biogenesis, and respiratory chain defects. They are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to assess MRPL1 expression levels, subcellular localization, and interactions. Dysregulation of MRPL1 has been linked to mitochondrial disorders, cancer, and neurodegenerative diseases, making these antibodies valuable in both basic and clinical research. For instance, reduced MRPL1 levels may indicate impaired mitochondrial translation, aiding in the diagnosis of metabolic syndromes.

When selecting MRPL1 antibodies, researchers prioritize specificity, validated applications, and cross-reactivity with relevant species (e.g., human, mouse). Many commercial antibodies are raised against peptide sequences unique to MRPL1 and undergo rigorous validation using knockout controls or siRNA-mediated silencing. Proper controls, such as mitochondrial markers, are recommended to confirm results. These tools continue to advance our understanding of mitochondrial dysfunction and its role in disease pathogenesis.

       
MRPL1抗体;MRPL1;MRPL1 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

MRPL1抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价